Results 161 to 170 of about 1,627,756 (267)

Multi-omics dissection of CPNE1 reveals its prognostic value and immune-regulatory function in liver cancer. [PDF]

Discov Oncol
Liu L, Hong H, Zhang W, Li X, Yao Y, Zhang Z, Li G.   +6 more
europepmc   +1 more source

Lenvatinib Plus Paclitaxel as Second‐Line Therapy for Advanced Gastric Cancer Patients: A Dose Escalation Exploratory Study

Advanced Science, EarlyView.
This study determines the maximum tolerated dose of lenvatinib in combination with paclitaxel as second‐line therapy for advanced gastric cancer patients. A dynamic network biomarker panel associated with patient prognosis and response to treatment is established.
Chenfei Zhou, Jinling Jiang, Liting Guo, Wenqi Xi, Junwei Wu, Qu Cai, Jun Ji, Feng Qi, Jun Zhang   +8 more
wiley   +1 more source

Epidemiology and surveillance for hepatocellular carcinoma: New trends.

Journal of Hepatology, 2020
A. Singal, P. Lampertico, P. Nahon
semanticscholar   +1 more source

NamiRNA‐Enhancer Network: The Changing Era Challenge and Chance of miRNA

Advanced Science, EarlyView.
MiRNAs (miRNAs) regulate diverse biological processes across species. Unlike canonical miRNA‐mediated gene repression, Nuclear Activating miRNAs (NamiRNAs) can efficiently upregulate gene expression by targeting enhancers. This review systematically summarizes recent advances in NamiRNA research, elucidates the theory of NamiRNA‐Enhancer‐mediated Gene ...
Lu Chen, Ying Liang, Hongyan Wei, Mengxing Liu, Jin Wu, Wei Li, Wenxuan Li, Yuxiao Jin, Yinshan Li, Wei Zhao, Min Xiao, Kaicheng Zhou, Shuai Yang, Wenqiang Yu   +13 more
wiley   +1 more source

Patients‐Derived Organoids Sequencing‐based FOXP4 Facilitates Radioresistance by Transcriptionally Modifying GPX4 to Regulate ferroptosis in Colorectal Cancer

Advanced Science, EarlyView.
FOXP4 regulates GPX4 transcription to suppress ferroptosis. In CRC patients, initial biopsies established PDO cultures alongside concurrent chemoradiotherapy. Post‐treatment MRI with mrTRG scoring stratified radioresistant/sensitive cohorts. Parallelly, 8Gy‐irradiated PDOs underwent viability‐based stratification.
Qianping Chen, Yuzhao Jin, Luyu Liao, Rong Shen, Xingnan Ge, Qingyu Jiang, Ying Huang, Quanquan Sun, Dong Liu, Luying Liu, Tongxin Liu, Qinghui Dai, Xiyuan Tang, Zhe Han, Xin Gao, Xinhua Lin, Wei Mao, Ji Zhu   +17 more
wiley   +1 more source

CACYBP expression predicts prognosis in hepatocellular carcinoma: A meta-analysis and bioinformatics validation. [PDF]

Medicine (Baltimore)
Odat RM, Yasin JA, Hussein AM, Qtaishat FA, Tamimi MA, Jain H, Alshwayyat S, Hanifa H, Nguyen D.   +8 more
europepmc   +1 more source

Interfacial Roughness‐Reinforced Magnetic Nanosheet Colloidal Gels for Stable Embolization and Magnetothermal Therapy of Hepatic Tumor

Advanced Science, EarlyView.
A rough‐interface reinforcement strategy is implemented to construct nanosheet‐mica‐based magnetic colloidal hydrogels with enhanced mechanical robustness and injectability. These hydrogels achieve stable vascular embolization and effective magnetothermal performance, offering synergistic therapeutic benefits in hepatic tumor treatment.
Xingyu Liu, Sheng Chen, Yonghong Song, Bing Chen, Xu Yan, Rui Qiu, Jinlong Hu, Baoqiang Cao, Hanye Xing, Tao Zhou, Liang Dong, Yang Lu   +11 more
wiley   +1 more source

Addressing the Unmet Need for Treatment in Advanced Hepatocellular Carcinoma With Child-Pugh C Cirrhosis: A Case of a Woman With Hepatocellular Carcinoma and Advanced Liver Disease. [PDF]

Cureus
Chamberlain E, Cleveland JM.
europepmc   +1 more source

PLAUR+ Neutrophils Drive Anti‐PD‐1 Therapy Resistance in Patients with Hepatocellular Carcinoma by Shaping an Immunosuppressive Microenvironment

Advanced Science, EarlyView.
The present study reveals that PLAUR+ neutrophils are enriched in immunotherapy non‐responders and correlate with poor prognosis. PLAUR+ neutrophils dictate immunotherapy resistance in hepatocellular carcinoma by forming an immunosuppressive tumor microenvironment characterized by CD8+ T cell exclusion and macrophage‐dependent immune suppression.
Shaoqing Liu, Yanzhao Zhou, Gaoxiang Li, Bingwen Zhu, Fang Wu, Jinxue Zhou, Xiaobing Chen, Bo Qin, Yanxia Gao, Fazhan Wang, Yong Jiang, Wenxin Xu   +11 more
wiley   +1 more source

[Retracted] MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma. [PDF]

Oncol Rep
Zhou J, Zhang Y, Qi Y, Yu D, Shao Q, Liang J.   +5 more
europepmc   +1 more source